NeurogesX, Inc.San Mateo, CA, United States (NASDAQ (GM): NGSX)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

NeurogesX Financial Statements

NeurogesX Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Edgar Online logo
This data is provided as per license from EDGAR Online

NeurogesX Income Statement

  2007 2006 2005
Revenue ($ mil.) 0.0 0.0 0.0
Gross Profit ($ mil.) -- -- --
Operating Income ($ mil.) (32.8) (27.0) (13.6)
Total Net Income ($ mil.) (32.0) (30.1) (13.1)
Diluted EPS (Net Income) (4.06) (116.20) (4.70)
More NeurogesX financial information

NeurogesX Stock Quote & Chart

10/10/08 14:49:20 EST • NASDAQ • 1.20 • Increased by 0.0000 • Increased by 0.0000 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

NeurogesX Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio -- 3.66 1.55
Price/Earnings Ratio 0.24 15.34 15.75
Price/Book Ratio 1.48 2.93 1.49
Price/Cash Flow Ratio -- 12.16 9.68
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed NeurogesX Financial Ratios

NeurogesX Competitive Intelligence

Eli Lilly Endo Pharmaceuticals Pfizer
Annual Sales ($ mil.) 18,633.5 1,085.6 48,418.0
Employees 40,600 1,208 86,600
Market Cap ($ mil.) 53,902.8 2,785.3 129,966.4

Competitive Landscape